97 related articles for article (PubMed ID: 9164324)
1. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia.
Basu T; Gale RE; Langabeer S; Linch DC
Lancet; 1997 May; 349(9063):1450. PubMed ID: 9164324
[No Abstract] [Full Text] [Related]
2. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia.
Sasai Y; Horiike S; Misawa S; Kaneko H; Kobayashi M; Fujii H; Kashima K; Taniwaki M
Leuk Res; 1999 Nov; 23(11):975-81. PubMed ID: 10576500
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase gene deletions in myelodysplasia.
Atoyebi W; Kusec R; Fidler C; Peto TE; Boultwood J; Wainscoat JS
Lancet; 1997 May; 349(9063):1450-1. PubMed ID: 9164325
[No Abstract] [Full Text] [Related]
4. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study.
Davies SM; Robison LL; Buckley JD; Radloff GA; Ross JA; Perentesis JP
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):563-6. PubMed ID: 10868689
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Naoe T; Tagawa Y; Kiyoi H; Kodera Y; Miyawaki S; Asou N; Kuriyama K; Kusumoto S; Shimazaki C; Saito K; Akiyama H; Motoji T; Nishimura M; Shinagawa K; Ueda R; Saito H; Ohno R
Leukemia; 2002 Feb; 16(2):203-8. PubMed ID: 11840286
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes.
Okada M; Okamoto T; Wada H; Takemoto Y; Kakishita E
Int J Hematol; 1997 Oct; 66(3):393-4. PubMed ID: 9401288
[No Abstract] [Full Text] [Related]
7. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect.
Chen H; Sandler DP; Taylor JA; Shore DL; Liu E; Bloomfield CD; Bell DA
Lancet; 1996 Feb; 347(8997):295-7. PubMed ID: 8569364
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia.
Crump C; Chen C; Appelbaum FR; Kopecky KJ; Schwartz SM; Willman CL; Slovak ML; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):457-60. PubMed ID: 10815689
[TBL] [Abstract][Full Text] [Related]
9. Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
Bolufer P; Collado M; Barragan E; Calasanz MJ; Colomer D; Tormo M; González M; Brunet S; Batlle M; Cervera J; Sanz MA
Br J Haematol; 2007 Feb; 136(4):590-6. PubMed ID: 17367411
[TBL] [Abstract][Full Text] [Related]
10. Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia.
Autrup JL; Hokland P; Pedersen L; Autrup H
Eur J Pharmacol; 2002 Mar; 438(1-2):15-8. PubMed ID: 11906705
[TBL] [Abstract][Full Text] [Related]
11. Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.
Preudhomme C; Nisse C; Hebbar M; Vanrumbeke M; Brizard A; Lai JL; Fenaux P
Leukemia; 1997 Sep; 11(9):1580-2. PubMed ID: 9305616
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia.
Lourenco GJ; Ortega MM; Nascimento H; Teori MT; De Souza CA; Costa FF; Lima CS
Eur J Haematol; 2005 Dec; 75(6):530-1. PubMed ID: 16313269
[No Abstract] [Full Text] [Related]
13. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia.
Davies SM; Robison LL; Buckley JD; Tjoa T; Woods WG; Radloff GA; Ross JA; Perentesis JP
J Clin Oncol; 2001 Mar; 19(5):1279-87. PubMed ID: 11230469
[TBL] [Abstract][Full Text] [Related]
14. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis.
Ye Z; Song H
Eur J Cancer; 2005 May; 41(7):980-9. PubMed ID: 15862746
[TBL] [Abstract][Full Text] [Related]
15. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB
Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of GSTT1, GSTM1 and NQO1 genes polymorphisms in myelodysplastic syndromes].
Yang L; Zou X; Zhang MR; Zhang Y; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):674-7. PubMed ID: 16620556
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome.
Mori N; Okada M; Motoji T; Mizoguchi H
Br J Haematol; 1999 Jun; 105(3):844-5. PubMed ID: 10354161
[No Abstract] [Full Text] [Related]
18. Activating mutations of JAK2V617F are uncommon in t-MDS and t-AML and are only observed in atypic cases.
Desta F; Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2006 Mar; 20(3):547-8. PubMed ID: 16424876
[No Abstract] [Full Text] [Related]
19. Antioxidant enzyme expression in myelodysplastic and acute myeloid leukemia bone marrow: further evidence of a pathogenetic role for oxidative stress?
Bowen D; Wang L; Frew M; Kerr R; Groves M
Haematologica; 2003 Sep; 88(9):1070-2. PubMed ID: 12969817
[No Abstract] [Full Text] [Related]
20. Inheritance and Myelodysplasia progression.
Giannouli S; Voulgarelis M
Leuk Res; 2013 Oct; 37(10):1185-6. PubMed ID: 23859717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
